| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |